About Gary Goldberg
Gary Goldberg is a founder and chief science officer at Sentrimed.
Gary Goldberg first appears on SEC filings in 2024.
Experience
This experience comes from Gary Goldberg's profile and from SEC filings. For roles taken from filings, the years are when the filings name Gary Goldberg in the role, so the role may have started earlier or lasted longer.
PB
PBLMed Current
Founder and Partner
2018 – Present
PC
PDPN Central Current
Founder and Leader
2016 – Present
RU
Rowan University Current
Professor
2013 – Present
Sentrimed, Inc. Current
Founder and Chief Science Officer
Founder and CSO (2011 – Present)
2011 – Present · Mullica Hill, NJ
Develops oral cancer treatments for people with head and neck cancer.
UU
University of Medicine & Dentistry of New Jersey (UMDNJ)
Associate Professor
2004 – 2013
NU
Nagoya University
Invited Professor
2010
SU
Stony Brook University
Research Assistant Professor
2000 – 2005
NJ
National Cancer Center of Japan
Invited Professor
1998 – 2003
UB
University at Buffalo
Research Assistant Professor
1995 – 2003
IO
International Agency for Research on Cancer / World Health Organization
Invited Researcher
1997
WU
Western University
Visiting Scientist
1994 – 1995
UC
University of Hawaii Cancer Center
Junior Researcher
1990 – 1993
Key Colleagues at Startups
The people Gary Goldberg works with at each company, as listed on that company's latest Form D.
Sentrimed, Inc. · Form D, May 13, 2026
AR
Arye Rosen
Vice President
JG
Jack Goldberg
Chief Medical Officer and director
MY
Mari Yin
Treasurer and director
WR
William Ragatz
President and CEO, director
CL
Christopher Leonard
Secretary
BG
Bradley Galer
Director
TD
Tabbetha Dobbins
Director